AVTX vs POOL · P/E 0.0, rev $441.0K vs P/E 18, rev $5.31B
Avalo Therapeutics Inc (AVTX) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the AVTX and POOL stock pages for the full models.
Not investment advice.